1. The use of heterologous antilymphoid agents in canine renal and liver homotransplantations and in human renal homotransplantations;Starzl;Surg Gynecol Obstet,1967
2. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transplant,2004
3. The UNOS scientific renal transplant registry. United Network for Organ Sharing;Cecka;Clin Transpl,1995
4. Both alloantigen-dependent and -independent factors influence chronic allograft rejection;Tullius;Transplantation,1995
5. Current and future immunosuppressive therapies: impact on chronic allograft dysfunction;Vella;J Nephrol,1997